UNSPSC 51281705: Bacampicillin

This classification denotes a penicillin antibiotic with the molecular formula C21H27N3O7S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8GM2J22278, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, 1-((ethoxycarbonyl)oxy)ethyl ester, (2s-(2alpha,5alpha,6beta(s*)))- but generally known as bacampicillin, which bears US NIH Compound Identifier 39849. Bacampicillin most often comes in base and hydrochloride forms.

UNSPSC 51281705 Bacampicillin is a Commodity code that in recent state and local procurement activity covers pharmaceutical products and medical supplies procured by health departments, fire rescue divisions, and state pharmacy benefit programs. The recent opportunities solicited under this code show a much broader scope than the code's nominal name suggests — state and local buying includes naloxone and drug deactivation systems, fire rescue medical and first aid supplies (respiratory equipment, cardiac monitoring, airway devices, bandaging materials, oxygen delivery systems), and generic multi-source pharmaceuticals and over-the-counter products distributed through state pharmacy benefit networks. Issuing bodies include county health departments (Seminole County, Florida), municipal fire departments (City of Tampa Fire Department Rescue Division), state health and human services commissions (Texas HHS Commission), and state cooperative purchasing alliances administering multi-jurisdictional pharmaceutical supply programs (Minnesota Multistate Cooperative Purchasing Alliance serving Minnesota, Oregon, and member jurisdictions). The code appears to capture pharmaceutical procurement across a range of public health, emergency response, and benefit-administration contexts rather than a single product category.

Recent activity spans Florida, Texas, Minnesota, and Oregon. Representative opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026; due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, the City of Tampa's IFB 26-P-00145 (posted March 25, 2026; due March 13, 2026) for 169 line items of medical and first aid supplies for the fire rescue division, estimated at $700,000, and designated as a sheltered market opportunity with a 5% bid discount for certified Small Local Business Enterprises; the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 (posted January 20, 2026; due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products through authorized wholesalers effective July 1, 2026; and the Texas HHS Commission's RFI HHS0017013 (posted April 3, 2026; due April 3, 2026) exploring direct-to-manufacturer prescription fulfillment capabilities. The Texas RFI signals potential future formal procurement activity around pharmacy benefit program restructuring, while the other three opportunities represent active, near-term contracting in emergency response and state pharmacy supply channels.